LivaNova PLC (LIVN) stock
LIVNNasdaqElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 13/3032% above fair value
$94.54+2.62 (+2.85%)
Close on Nov 18, 2026Market cap $5.21BP/E 27.9Yield –
LivaNova profit margin
Profit margin (net margin) is net income as a percentage of revenue.
LivaNova's profit margin for the twelve months ending Jun 30, 2026 was 12.8%. For fiscal 2025 it was -17.5%, against 5.0% the year before. The highest annual figure on record is 19.8% in fiscal 2015.
Annual profit margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -17.5% | −22.5 |
| FY2024 | Dec 31, 2024 | 5.0% | +3.5 |
| FY2023 | Dec 31, 2023 | 1.5% | +10.0 |
| FY2022 | Dec 31, 2022 | -8.4% | +4.7 |
| FY2021 | Dec 31, 2021 | -13.1% | +24.2 |
| FY2020 | Dec 31, 2020 | -37.3% | −22.8 |
| FY2019 | Dec 31, 2019 | -14.5% | +2.6 |
| FY2018 | Dec 31, 2018 | -17.1% | −14.6 |
| FY2017 | Dec 31, 2017 | -2.5% | −22.3 |
| FY2015 | Apr 24, 2015 | 19.8% | +0.4 |
| FY2014 | Apr 25, 2014 | 19.5% | +1.2 |
| FY2013 | Apr 26, 2013 | 18.2% | – |
Quarterly profit margin
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q2 FY2026CQ2 2026 | Jun 30, 2026 | 27.8% | +20.1 |
| Q1 FY2026CQ1 2026 | Mar 31, 2026 | 6.2% | +109.5 |
| Q4 FY2025CQ4 2025 | Dec 31, 2025 | 8.6% | −8.8 |
| Q3 FY2025CQ3 2025 | Sep 30, 2025 | 7.5% | −2.9 |
| Q2 FY2025CQ2 2025 | Jun 30, 2025 | 7.7% | +2.6 |
| Q1 FY2025CQ1 2025 | Mar 31, 2025 | -103.3% | −89.1 |
| Q4 FY2024CQ4 2024 | Dec 31, 2024 | 17.4% | +12.1 |
| Q3 FY2024CQ3 2024 | Sep 30, 2024 | 10.4% | +12.9 |
| Q2 FY2024CQ2 2024 | Jun 30, 2024 | 5.1% | +4.7 |
| Q1 FY2024CQ1 2024 | Mar 31, 2024 | -14.2% | −17.0 |
| Q4 FY2023CQ4 2023 | Dec 31, 2023 | 5.3% | +4.7 |
| Q3 FY2023CQ3 2023 | Sep 30, 2023 | -2.6% | +39.9 |
| Q2 FY2023CQ2 2023 | Jun 30, 2023 | 0.4% | −6.1 |
| Q1 FY2023CQ1 2023 | Mar 31, 2023 | 2.8% | +1.6 |
| Q4 FY2022CQ4 2022 | Dec 31, 2022 | 0.6% | +2.5 |
| Q3 FY2022CQ3 2022 | Sep 30, 2022 | -42.5% | −25.3 |
| Q2 FY2022CQ2 2022 | Jun 30, 2022 | 6.5% | +27.8 |
| Q1 FY2022CQ1 2022 | Mar 31, 2022 | 1.2% | +13.7 |
| Q4 FY2021CQ4 2021 | Dec 31, 2021 | -1.9% | +102.4 |
| Q3 FY2021CQ3 2021 | Sep 30, 2021 | -17.2% | −11.0 |
| Q2 FY2021CQ2 2021 | Jun 30, 2021 | -21.4% | +27.7 |
| Q1 FY2021CQ1 2021 | Mar 31, 2021 | -12.4% | −27.5 |
| Q4 FY2020CQ4 2020 | Dec 31, 2020 | -104.3% | −54.5 |
| Q3 FY2020CQ3 2020 | Sep 30, 2020 | -6.2% | −18.1 |
| Q2 FY2020CQ2 2020 | Jun 30, 2020 | -49.1% | −38.5 |
| Q1 FY2020CQ1 2020 | Mar 31, 2020 | 15.0% | +21.0 |
| Q4 FY2019CQ4 2019 | Dec 31, 2019 | -49.8% | +21.1 |
| Q3 FY2019CQ3 2019 | Sep 30, 2019 | 12.0% | +14.6 |
| Q2 FY2019CQ2 2019 | Jun 30, 2019 | -10.5% | −15.8 |
| Q1 FY2019CQ1 2019 | Mar 31, 2019 | -5.9% | −11.2 |
| Q4 FY2018CQ4 2018 | Dec 31, 2018 | -70.9% | −30.8 |
| Q3 FY2018CQ3 2018 | Sep 30, 2018 | -2.6% | −13.7 |
| Q2 FY2018CQ2 2018 | Jun 30, 2018 | 5.2% | −13.3 |
| Q1 FY2018CQ1 2018 | Mar 31, 2018 | 5.3% | +0.3 |
| Q4 FY2017CQ4 2017 | Dec 31, 2017 | -40.1% | −54.3 |
| Q3 FY2017CQ3 2017 | Sep 30, 2017 | 11.1% | −11.9 |
| Q2 FY2017CQ2 2017 | Jun 30, 2017 | 18.6% | – |
| Q1 FY2017CQ1 2017 | Mar 31, 2017 | 5.0% | – |
| Q4 FY2015CQ1 2015 | Apr 24, 2015 | 14.2% | – |
| Q3 FY2015CQ4 2014 | Jan 23, 2015 | 23.0% | – |
See a number that looks wrong?